Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

FORGOTTEN HISTORY: Auph - The Untold Story

FDA Drug Chief George Tidmarsh Resigns After Allegations Of Power Misuse

George Tidmarsh, head of the Food and Drug Administration’s (FDA) drug center, resigned Sunday following allegations that he misused his regulatory power to financially harm a former business associate.

Benzinga · Nov 3, 2025

Is Aurinia Pharmaceuticals Poised for Growth in the Biotech Space?

Aurinia Pharmaceuticals (AUPH) released its third-quarter results, reporting solid revenue growth and robust cash flow from operations. Solid demand for its product offerings, restructuring strategies, and sound financials remain key drivers of the company’s growth and success. So, let’s analyze whether AUPH is a buy today. Read more to find…

StockNews.com · Jan 14, 2025

Top 4 Pharma Stocks to Consider This Month

With growing medical needs globally, R&D initiatives, and rapid adoption of emerging technologies like genAI, the pharma industry is well-poised to experience robust expansion. Thus, investors could consider buying top pharma stocks MEI Pharma (MEIP), Hypera (HYPMY), Aurinia Pharmaceuticals (AUPH), and Bayer (BAYRY) this month. Read on.

StockNews.com · May 13, 2024

From analysis to the latest developments in health,
read the most diverse news in one place.

What 4 Analyst Ratings Have To Say About Aurinia Pharmaceuticals

Over the past 3 months, 4 analysts have published their opinion on Aurinia Pharmaceuticals (NASDAQ:AUPH) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga · Mar 8, 2022

Why Aurinia Pharmaceuticals Shares Are Falling Today

Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) is trading significantly lower Monday after the company reported declining fourth-quarter financial results on a year-over-year basis.

Benzinga · Feb 28, 2022

Coverage From

People

Marty Makary

133 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

FDA

7,624 stories

the Food and Drug Administration

237 stories

Medical Pharmaceuticals

Bayer Aktiengesellschaft

12 stories

Pharmaceuticals

11 stories

Read news from The Economist, FT, and more,
with one subscription

Places

United States

420,302 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.